CUC Past Earnings Performance
Past criteria checks 2/6
CUC has been growing earnings at an average annual rate of 10.8%, while the Healthcare industry saw earnings growing at 6% annually. Revenues have been growing at an average rate of 13% per year. CUC's return on equity is 9.3%, and it has net margins of 7.9%.
Key information
10.8%
Earnings growth rate
3.2%
EPS growth rate
| Healthcare Industry Growth | 7.9% |
| Revenue growth rate | 13.0% |
| Return on equity | 9.3% |
| Net Margin | 7.9% |
| Last Earnings Update | 31 Mar 2024 |
Revenue & Expenses BreakdownBeta
How CUC makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 33,025 | 2,595 | 12,206 | 0 |
| 31 Dec 23 | 31,133 | 1,779 | 11,432 | 0 |
| 30 Sep 23 | 31,862 | 1,952 | 10,802 | 0 |
| 30 Jun 23 | 32,737 | 1,992 | 10,459 | 0 |
| 31 Mar 23 | 35,210 | 2,423 | 10,015 | 0 |
| 31 Mar 22 | 35,314 | 2,707 | 8,788 | 0 |
| 31 Mar 21 | 16,606 | 1,100 | 5,711 | 0 |
Quality Earnings: 9158 has high quality earnings.
Growing Profit Margin: 9158's current net profit margins (7.9%) are higher than last year (6.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 9158's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare 9158's past year earnings growth to its 5-year average.
Earnings vs Industry: 9158 earnings growth over the past year (7.1%) did not outperform the Healthcare industry 8.4%.
Return on Equity
High ROE: 9158's Return on Equity (9.3%) is considered low.